01
Target Identification and Validation
AI-driven analysis across multimodal biological datasets to surface and prioritise high-confidence, druggable targets — focusing resources where translational potential is strongest.
Capabilities
What We Do
Alyssum Labs develops AI-driven intelligence systems and embeds them into complex, high-stakes programmes. We currently operate across two sectors.
Sector
Life Sciences
The biological, chemical, and clinical data that informs drug discovery and development has grown beyond the reach of conventional analytical methods. Speed, precision, and the ability to interrogate large multimodal datasets are now as critical to programme success as the science itself.
Alyssum Labs provides the computational infrastructure that addresses this — as a dedicated technology layer within partner programmes.
Intelligence pipeline
From multimodal data to translational clarity
02
Molecule Design and Optimisation
Generative AI and synthesis-aware workflows for the design and iterative refinement of drug candidates — scored for potency, selectivity, and developability, with each cycle improving on the last.
03
Development Intelligence
Structured analysis of clinical landscapes, regulatory precedent, and competitive pipelines — enabling partners to build development strategies grounded in evidence and regulatory logic.
04
Data Infrastructure
Architecture and management of biological and chemical data assets — structured for machine learning readiness, regulatory compliance, and downstream commercialisation.